Celldex Therapeutics Inc

FRA:TCE2 (USA)  
€ 39.60 (+5.32%) Sep 16
At Loss
P/B:
3.49
Market Cap:
€ 2.56B ($ 2.85B)
Enterprise V:
€ 1.84B ($ 2.05B)
Volume:
-
Avg Vol (2M):
69.00
Trade In:

Celldex Therapeutics Inc (FRA:TCE2) Stock News, Headlines & Updates